The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 31 March 2003 doi:10.1084/jem.20021624
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 183K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saulquin, X.
Right arrow Articles by Vivier, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saulquin, X.
Right arrow Articles by Vivier, E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*Protein*Structure
*UniGene
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© Rockefeller University Press, 0022-1007/2003/4/933 $5.00
The Journal of Experimental Medicine, Volume 197, Number 7, 933-938


Brief Definitive Report

Crystal Structure of the Human Natural Killer Cell Activating Receptor KIR2DS2 (CD158j)

Xavier Saulquin1, Louis N. Gastinel2 and Eric Vivier1

1 Centre d'Immunologie de Marseille-Luminy, Centre National de la Recherche Scientifique (CNRS)–Institut National de la Santé et de la Recherche Médicale (INSERM)–Université de la Méditerranée, Campus de Luminy, Case 906, 13288 Marseille Cedex 09, France
2 Architecture et Fonction des Macromolecules Biologiques, CNRS UMR 6098, 13402 Marseille Cedex 20, France

Address correspondence to Eric Vivier, Centre d'Immunologie INSERM-CNRS, de Marseille Luminy, Case 906, Parc Scientifique de Luminy, Marseille Cedex 09, 13288 France. Phone: 33-4-91-26-94-44; Fax: 33-4-91-26-94-30; E-mail: vivier{at}ciml.univ-mrs.fr; or Louis N. Gastinel at his present address, Institut des Sciences de la Vie et de la Santé, UMR 1061, Institut National de la Recherche Agronomique, Université de Limoges, Faculté des Sciences, 123 Avenue Albert Thomas, 87060 Limoges Cedex, France. Phone: 33-0-5-55-45-76-60; Fax: 33-0-5-55-45-76-53; E-mail: lgastinel{at}unilim.fr

Killer cell Ig-like receptors (KIRs) regulate the function of human natural killer and T cell subsets. A feature of the KIR locus is the clustering of homologous genes encoding for inhibitory and activating KIR. Inhibitory and activating KIR differ for ligand specificities and/or affinities. In particular, we show here with KIR tetramers that activating KIR2DS2 does not bind HLA-Cw3 molecules recognized by inhibitory KIR2DL2, despite 99% extracellular amino acid identity. We also report the 2.3-Å structure of KIR2DS2, which reveals subtle displacements of two residues (Tyr45 and Gln71) involved in the interaction of KIR2DL2 with HLA-Cw3. These results show that KIR molecules cannot tolerate any variability in their three-dimensional structure without altering their MHC class I recognition capacities. Therefore, the mode of recognition used by KIR largely differs from the conformational changes that characterize T cell receptor or NKG2D interaction with their respective ligands.

Key Words: KIR • crystal structure


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS